Symbiotics to Prevent Postoperative Infection in Colorectal Cancer

Colorectal Cancer Clinical Trial

Official title: Change in Incidence of Surgical Site Infection After Resection of Colorectal Cancer Between Patients Receiving a Symbiotic Compound and Patients Receiving a Placebo.

Status Recruiting

Clinical Trial Summary

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. The researchers will compare incidence of surgical site infection between the study groups.

Clinical Trial Description

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be randomly selected to receive either a symbiotic formulation or placebo during the perioperative period. The researchers will compare incidence of surgical site infection, detected by clinical examination and complementary tests (CT scans, X-rays, microbiological and hematological tests) between the study groups. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms
• Infection
• Surgical Site Infection
• Surgical Wound Infection

• NCT number: NCT02571374
• Study type: Interventional
• Source: Hospital de Clinicas de Porto Alegre
• Contact: Aline Taborda, ms
• Phone: 555130849948
• Email: alinegamarrat@hotmail.com
• Status: Recruiting
• Phase: N/A
• Start date: October 2013
• Completion date: December 2016